Laurel Habel to Antineoplastic Agents
This is a "connection" page, showing publications Laurel Habel has written about Antineoplastic Agents.
Connection Strength
0.482
-
The?application of lag times in cancer pharmacoepidemiology: a narrative review. Ann Epidemiol. 2023 08; 84:25-32.
Score: 0.218
-
Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care. 2012 Nov; 18(11):704-12.
Score: 0.105
-
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
Score: 0.104
-
Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8.
Score: 0.029
-
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
Score: 0.026